Table 2.
Antimicrobial resistance pattern that predict ESBL phenotype
| Predictive drug resistance phenotype |
ESBL n (%) |
OR (95% CI) |
p- value |
|
|---|---|---|---|---|
| Yes | No | |||
|
AAGCS |
|
|
|
|
| Yes |
12 (44.4) |
15 (55.6) |
3.50 (1.5-8.3) |
0.004 |
| No |
29 (18.6) |
127 (81.4) |
1 |
|
|
AAG |
|
|
|
|
| Yes |
30 (44.8) |
37 (55.2) |
7.74 (3.5-17.0) |
<0.001 |
| No |
11(9.48) |
105 (90.5) |
1 |
|
|
AAC |
|
|
|
|
| Yes |
14 (43.8) |
18 (56.3) |
3.57 (1.6-8.1) |
0.002 |
| No |
27 (17.9) |
124 (82.1) |
1 |
|
|
GCS |
|
|
|
|
| Yes |
12 (42.9) |
16 (57.1) |
3.26 (1.4-7.6) |
0.006 |
| No |
29 (18.7) |
126 (81.3) |
1 |
|
|
GC |
|
|
|
|
| Yes |
12 (42.9) |
16 (57.1) |
3.26 (1.4-7.6) |
0.006 |
| No |
29 (18.7) |
126 (81.3) |
1 |
|
|
GS |
|
|
|
|
| Yes |
33 (45.8) |
39 (54.2) |
10.89 (4.6-25.6) |
<0.001 |
| No | 8 (7.2) | 103 (92.8) | 1 | |
Note: AAGCS = A- Ampicillin, A- Amoxicillin/Clavulanate, G- Gentamicin, C-Ciprofloxacin, and S- trimethoprim-sulphamethoxazole, AAG = A- Ampicillin, A- Augmentin, G- Gentamicin, AAC = A- Ampicillin, A- Augmentin, C- Ciprofloxacin, GCS = G- Gentamicin, C- Ciprofloxacin, S- trimethoprim-sulphamethoxazole, GC = G- Gentamicin, C- Ciprofloxacin, GS = G- Gentamicin, S- trimethoprim-sulphamethoxazole.